X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2868445/0/en/Biolojic-Design-Announces-that-Nektar-Therapeutics-Has-Exercised-Its-License-Option-to-Develop-an-AI-Designed-Agonistic-Antibody-Targeting-TNFR2-for-the-Treatment-of-Autoimmune-Dis.html